文献速递介入技术与安全腹部US

经皮微波消融用于术后止血的安全性与有效性:一项双中心回顾性研究

Safety and efficacy of percutaneous microwave ablation for post-procedural haemostasis: a bi-central retrospective study focusing on safety and efficacy.
PubMed 文献 · Br J Radiol · 2019-12-12

该双中心回顾性研究纳入10例医源性出血患者,采用经皮微波消融(MWA)止血,术前用多普勒超声及超声造影定位活动性出血源并引导天线置入,术后评估有无活动性外渗。

要点

  • MWA可用于经选择的医源性出血病例的经皮止血。
  • 术前多普勒超声联合超声造影可定位活动性出血源并引导天线置入。
  • 消融终点为多普勒成像与超声造影上活动性外渗均消失。

核心结论

  • 有限经验初步显示,MWA可能成为医源性出血经皮治疗手段之一。
  • 作者认为需更多前瞻性研究、更大样本验证该技术并评估经皮消融在出血治疗流程中的位置。

研究设计与样本

  • 双中心回顾性研究,机构数据库回顾性检索。
  • 共纳入10例因医源性出血接受经皮MWA止血的病例。
  • 术前采用多普勒超声及超声造影识别活动性出血源,并作为天线置入的引导方式;消融后评估有无活动性外渗。
  • 靶部位包括肝脏、肋间隙、脾脏及甲状腺。
  • 技术成功定义为天线置于目标位置;治疗终点为多普勒成像与超声造影上活动性外渗均消失。

关键影像表现/征象

  • 所有病例均实现技术成功,即天线置于目标位置。
  • 消融后多普勒成像与超声造影评估显示活动性外渗消失。
  • 出院前影像与临床随访均未显示活动性外渗或出血征象。

诊断标准与关键数值

  • 技术成功:天线置于目标位置,所有病例均达成。
  • 治疗终点:多普勒成像与超声造影上活动性外渗均消失。

临床应用与阅片要点

  • 术前可用多普勒超声联合超声造影识别活动性出血源并引导天线置入。
  • 消融后以多普勒成像与超声造影确认活动性外渗消失作为治疗终点。
  • 作者认为经皮消融可能在经选择的病例中发挥止血作用。

局限性

  • 作者称本研究为有限经验,报告的是初步数据。
  • 作者认为需更多前瞻性研究、更大样本验证该技术并得出更广泛结论。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To review safety and efficacy of percutaneous microwave ablation (MWA) for post-procedural haemostasis.

METHODS: Institutional databases retrospective research identified 10 cases of iatrogenic bleeding who underwent percutaneous MWA for post-procedural haemostasis. Ultrasound examination with Doppler and contrast enhancement identified a source of active bleeding prior to ablation; additionally they were used as guiding modality for antenna insertion whilst, post-ablation, assessed the lack of active extravasation. Target locations included liver intercostal space spleen and thyroid gland. Technical success was defined as positioning of the antenna on the desired location. Treatment end point was considered the disappearance of active extravasation in both Doppler imaging and contrast-enhanced ultrasound.

RESULTS: Technical success (i.e. positioning of the antenna on the desired location) was achieved in all cases. No complications were noted. All patients post MWA remained haemodynamically stable with no need for transfusion and were discharged from the hospital the next morning. Imaging and clinical follow-up in all patients before exiting the hospital did not depict any sign of active extravasation or bleeding.

CONCLUSION: Our limited experience reports preliminary data showing that MWA could be added in the armamentarium of percutaneous therapies for iatrogenic bleeding. More prospective studies with larger patient samples are necessary for verification of this technique as well as for drawing broader conclusions in order to evaluate the place of percutaneous ablation in the treatment algorithm of haemorrhage.

ADVANCES IN KNOWLEDGE: Percutaneous ablation might have a role in haemostasis in well-selected cases.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Jiang T, Kelekis A, Zhao Q, et al. Safety and efficacy of percutaneous microwave ablation for post-procedural haemostasis: a bi-central retrospective study focusing on safety and efficacy. Br J Radiol. 2019. PMID: 31794250. doi:10.1259/bjr.20190615

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。